Hypera-Sanofi deal faces in-depth review in Brazil
MLex Summary: Hypera's planned buyout of 12 medicine brands from Sanofi Medley Farmacêutica will face an in-depth review in Brazil, after the national competition authority declared the deal complex, according to...To view the full article, register now.
Already a subscriber? Click here to view full article